Scripps Research, Florida, Florida, United States
Virneliz Fernández Vega is an Assay Development Scientific Associate in the Lead Identification/High Throughput Screening Division in the Department of Molecular Medicine at the Scripps Research in the Florida Campus since 2008. Her main focus involves the implementation and validation of physiological relevant 3D cell culture models of pancreas, brain and lung cancer for drug target screening using HTS automation. Also, she develops and implements biochemical and cell-based assays compatible for uHTS campaigns to screen large compound libraries for drug discovery of a multidisciplinary range of therapeutic areas including cancer, autoimmune diseases, neurological disorders and infectious diseases.
Before joining Scripps Florida, Mrs. Fernández Vega worked at the University of Miami studying the gene expression of transcription factors involved in breast cancer and tumor growth development. Prior to joining University of Miami in 2002, she worked in the Laboratory of Infectious Diseases in the Epidemiology Section at the National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health in Bethesda, MD. Her primary focus was the characterization of the Norwalk virus N-terminal protein. Mrs. Fernández Vega graduated from the University of Puerto Rico with a major in Microbiology in 2001.
Disclosure information not submitted.
Tuesday, February 8, 2022
9:00 AM – 10:00 AM
Wednesday, February 9, 2022
11:00 AM – 11:30 AM